Tubeless Insulin Pump Market Size Report, Industry Share, Analysis, Growth, 2032

Tubeless Insulin Pump Industry Perspective:

The global tubeless insulin pump market size accrued earnings worth approximately USD 2.03 Billion in 2023 and is predicted to gain revenue of about USD 9.54 Billion by 2032, is set to record a CAGR of nearly 18.89% over the period from 2024 to 2032.

Request Free Sample

The report offers valuation and analysis of Tubeless Insulin Pump Market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, revenue estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on value (USD Million).

Tubeless Insulin Pump Market: Overview

A handheld medical device, the tubeless insulin pump helps regulate blood glucose levels. It consists of key components such as a pod or patch, a remote, and various accessories, including batteries and reservoirs. The primary purpose of these devices is to decrease the frequency of injections. Hospitals, pharmacies, and e-commerce platforms extensively utilize the different components of these pumps—pod/patch, remote, and accessories.

Insulin pump which is also referred to as continuous subcutaneous insulin infusion is rapidly gaining popularity across the medical device industry. This medical device makes use of near-physiologic basal-bolus procedure for delivery of insulin and it is flexible as well as lifestyle-friendly method.

Request Free Sample

Moreover, tubeless insulin pumps are tiny, unobtrusive, and lightweight in nature and are also referred as insulin patch pumps. These products are discrete, cost-effective, easily adhere to the human body, and easy to use. As per NCBI, patients having type 1 diabetes prefer tubeless insulin pumps. Currently, these pumps make use of Nitinol Wire, Spring, Step Motor, Piezoelectric crystal, Manual pumping chamber, and bladder for insulin delivery. These tubeless insulin pumps are available in myriad sizes and technologies.  These products can be worn and effectively handled under clothing.

Various players developed tubeless insulin pumps and received approval for product promotion from regulatory authorities like the U.S. FDA across the United States of America. For instance, Solo™ MicroPump Insulin Delivery System and Finesse™ were the products that received approval from the U.S. FDA authorities for marketing purpose in year 2010. For the record, OmniPod® Insulin Management System developed by Insulet Corporation was the first tubeless insulin pump advertised in the U.S.

Tubeless Insulin Pump Market: Growth Drivers

Tube insulin pumps help in both bolus as well as basal rate of insulin delivery. These products help in minimizing glycemic variability and facilitate in bringing an improvement in glycemic control. All these factors will steer the growth of the tubeless insulin pump industry over the forecast period.  

Furthermore, the product reduces the risk of hypoglycemia and the requirement for medical care. This has lowered medical care costs and optimized the utility of healthcare resources. Reportedly, clinical trials and observations have displayed progression in long-term glycemic control over routine multiple-dose insulin injections.  Apart from this, the use of tubeless insulin pumps has brought an improvement in the quality of life measures as compared to multiple-dose insulin injections. The rise in diabetics across the globe will define business growth in the near future. The addition of new products to the product line and the constant addition of new features to the existing products will boost the market trends and enlarge the scope of the market over the coming years.

Tubeless Insulin Pump Market: Report Scope

Remote Tubeless Insulin Pump Market To Register Highest Gains Over 2024-2032

The remote tubeless insulin pump business is slated to record the highest CAGR of nearly 29% during the forecast period. The growth is attributed to the huge acceptance of the component for preventing pain during insulin delivery. Also, the growing demand for remote tubeless insulin pumps is likely owing to a rise in the number of persons affected due to type 1 diabetes.

E-commerce Segment To Dominate Distribution Channel Segment By 2032

The segmental growth during the forecast period is credited to huge online distribution product offers to increase the sales of tubeless insulin pumps for diabetics. Apart from this, rise in the internet penetration across the globe will further impel the growth of the segment over the forthcoming years. The thriving e-commerce sector in the countries like the U.S. is expected to open new horizons of growth for the tubeless insulin market over the foreseeable future.

North American Market To Accrue Huge Revenue Over The Forecast Period

The rise in the diabetic populace in the countries like the U.S. and Canada along with the presence of established players in the region will prompt the regional market growth over the forecast timespan.

Moreover, a rise in the occurrence of type 1 and type 2 diabetes in Europe will prop up the market growth in the region over the forecast period.

Tubeless Insulin Pump Market: Competitive Space

Key players involved in the tubeless insulin pump business and profiled in the report include

• Abbott
• Insulet Corporation.
• F. Hoffmann-La Roche Ltd
• Debiotech S.A
• CeQur Corporation.
• Terumo Corporation
• Tandem Diabetes Care Inc.
• Johnson & Johnson Private Limited.
• Copernicus
• Medtronic
• Siemens
• Koninklijke Philips N.V.
• B. Braun Melsungen AG
• BD
• Cardinal Health.
• Cook.
• Stryker
• Bayer AG
• Merck & Co. Inc.
• GE Healthcare and Medtrum Technologies Inc.
• among others.

The global tubeless insulin pump market can be segmented as follows:

By Component

• Pod/Patch
• Remote
• Accessories (reservoirs, batteries, etc.)

By Distribution Channel

• Hospitals
• Pharmacies
• E-commerce

By Region

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa